Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningeal Neoplasms × patritumab deruxtecan × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Meningeal Neoplasms 1 Breast Neoplasms 1

Interventions

Trastuzumab 2 Radiotherapy 2 Capecitabine 2 tucatinib 1 sapanisertib 1 pertuzumab 1 patritumab deruxtecan 1 paclitaxel-Angiopep-2 conjugate 1 omburtamab I-131 1 fludarabine 1 eribulin 1 avelumab 1 WP 744 1 Temozolomide 1 Rituximab 1 Methotrexate 1 Cyclophosphamide 1 Amplified Fragment Length Polymorphism Analysis 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05865990 2026-03-12

TUXEDO-3

MedSIR

Phase 2 Active not recruiting

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡